These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37016156)

  • 21. Implications of intraindividual variability in bioavailability studies of furosemide.
    Grahnén A; Hammarlund M; Lundqvist T
    Eur J Clin Pharmacol; 1984; 27(5):595-602. PubMed ID: 6519165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-period double-dosing for simultaneous evaluation of intestinal absorption and hepatic disposition in a single conscious rat using cephalexin as test drug.
    Ito T; Yamaoka K; Nakagawa T
    J Pharm Pharmacol; 1997 Dec; 49(12):1189-94. PubMed ID: 9466341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanistic basis for unexpected bioavailability enhancement of polyelectrolyte complexes incorporating BCS class III drugs and carrageenans.
    Heinen C; Reuss S; Saaler-Reinhardt S; Langguth P
    Eur J Pharm Biopharm; 2013 Sep; 85(1):26-33. PubMed ID: 23958316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.
    Darwich AS; Neuhoff S; Jamei M; Rostami-Hodjegan A
    Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A note on population analysis of dissolution-absorption models using the inverse Gaussian function.
    Wang J; Weiss M; D'Argenio DZ
    J Clin Pharmacol; 2008 Jun; 48(6):719-25. PubMed ID: 18359921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trospium chloride in the management of overactive bladder.
    Rovner ES
    Drugs; 2004; 64(21):2433-46. PubMed ID: 15482001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics, absolute bioavailability, and absorption characteristics of lamivudine.
    Yuen GJ; Morris DM; Mydlow PK; Haidar S; Hall ST; Hussey EK
    J Clin Pharmacol; 1995 Dec; 35(12):1174-80. PubMed ID: 8750368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multiscale absorption and transit model for oral delivery of hydroxychloroquine: Pharmacokinetic modeling and intestinal concentration prediction to assess toxicity and drug-induced damage in healthy subjects.
    Kannan R; Przekwas A
    Int J Numer Method Biomed Eng; 2020 Dec; 36(12):e3403. PubMed ID: 33029911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption.
    Wilkins JJ; Savic RM; Karlsson MO; Langdon G; McIlleron H; Pillai G; Smith PJ; Simonsson US
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2138-48. PubMed ID: 18391026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating bioavailability when clearance varies with time.
    Karlsson MO; Sheiner LB
    Clin Pharmacol Ther; 1994 Jun; 55(6):623-37. PubMed ID: 8004879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of intestinal availability of various drugs in the oral absorption process using portal vein-cannulated rats.
    Matsuda Y; Konno Y; Satsukawa M; Kobayashi T; Takimoto Y; Morisaki K; Yamashita S
    Drug Metab Dispos; 2012 Dec; 40(12):2231-8. PubMed ID: 22930277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Integrated Population Pharmacokinetic Analysis for Posaconazole Oral Suspension, Delayed-Release Tablet, and Intravenous Infusion in Healthy Volunteers.
    Chen L; Krekels EHJ; Heijnen AR; Knibbe CAJ; Brüggemann RJ
    Drugs; 2023 Jan; 83(1):75-86. PubMed ID: 36607589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference.
    Moriwaki T; Yasui H; Yamamoto A
    J Pharmacokinet Pharmacodyn; 2003 Apr; 30(2):119-44. PubMed ID: 12942684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population pharmacokinetics of mizoribine in adult recipients of renal transplantation.
    Ishida K; Okamoto M; Ishibashi M; Hashimoto Y
    Clin Exp Nephrol; 2011 Dec; 15(6):900-6. PubMed ID: 21751083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variability of bioavailability and intestinal absorption mechanisms of metoprolol.
    Fukao M; Ishida K; Horie A; Taguchi M; Nozawa T; Inoue H; Hashimoto Y
    Drug Metab Pharmacokinet; 2014; 29(2):162-7. PubMed ID: 24025984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The rate and extent of oral bioavailability versus the rate and extent of oral absorption: clarification and recommendation of terminology.
    Chiou WL
    J Pharmacokinet Pharmacodyn; 2001 Feb; 28(1):3-6. PubMed ID: 11253613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers.
    Pietzko A; Dimpfel W; Schwantes U; Topfmeier P
    Eur J Clin Pharmacol; 1994; 47(4):337-43. PubMed ID: 7875185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trospium chloride: the European experience.
    Madersbacher H; Rovner E
    Expert Opin Pharmacother; 2006 Jul; 7(10):1373-80. PubMed ID: 16805722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the pharmacokinetics and metabolism of propiverine in man.
    Haustein KO; Hüller G
    Eur J Drug Metab Pharmacokinet; 1988; 13(2):81-90. PubMed ID: 3208795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.